SCHEMBL20469219

SCHEMBL20469219

N=C/C(=C\NC(F)F)c1ccc(C=O)c(F)c1

nearest known ligand 0.40

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ERN1 O75460 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20468995 0.81 — —
SCHEMBL20469165 0.78 ALDH1A1 (0.39) —
SCHEMBL14971531 0.78 ERN1 (0.36) ERN1
SCHEMBL20469090 0.75 ERN1 (0.31) ERN1
SCHEMBL24018468 0.71 HPGD (0.34) —
SCHEMBL2981118 0.67 ERN1 (0.54) ERN1
SCHEMBL30423616 0.66 HDAC6 (0.59) —
SCHEMBL25215904 0.66 HDAC6 (0.59) —
SCHEMBL15652131 0.65 ERN1 (0.55) ERN1
SCHEMBL12703704 0.65 ERN1 (0.42) ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3909949-A1 ATAZANAVIR (ATV) ANALOGUES FOR TREATING HIV INFECTIONS Gilead Sciences, Inc. (US) 2021-11-17 — — EP disclosed
EP-3577110-B1 8-OXETAN-3-YL-3,8-DIAZABICYCLO[3.2.1]OCTAN-3-YL SUBSTITUTED COMPOUNDS AS HIV INHIBITORS GILEAD SCIENCES INC (US) 2021-04-21 — — EP disclosed
WO-2018145021-A1 ATAZANAVIR (ATV) ANALOGUES FOR TREATING HIV INFECTIONS GILEAD SCIENCES, INC. (US) 2018-08-09 — — WO disclosed
Send feedback